Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|August 30, 2024
Nutrient competition predicts gut microbiome restructuring under drug perturbationsHanduo Shi, Daniel P Newton, Taylor H Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine responseSamantha H Chiang, Michael Tu, Jordan Cheng, et al.
Plos One|July 1, 2021
Development and validation of a quantitative, non-invasive, highly sensitive and specific, electrochemical assay for anti-SARS-CoV-2 IgG antibodies in salivaSamantha H Chiang, Michael Tu, Jordan Cheng, et al.
Vaccine: X|December 17, 2024
Parental motivations and perceived barriers to participating in pediatric vaccine clinical trials: Findings from the OCV-S trial in NepalRam Hari Chapagain, Santosh Adhikari, Kshitij Kunwar, et al.
Cell|November 18, 2025
Nutrient competition predicts gut microbiome restructuring under drug perturbationsHanduo Shi, Daniel P Newton, Taylor H Nguyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2024
Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023Moti Edosa, Yeonji Jeon, Abel Gedefaw, et al.
Human Vaccines & Immunotherapeutics|October 16, 2024
Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, NepalShipra Chaudhary, Surendra Uranw, Basant Rai, et al.
The American Journal of Tropical Medicine and Hygiene|October 2, 2023
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1Meagan Kelly, Suhi Jeon, Jeesun Yun, et al.
Vaccine|December 28, 2019
Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccineFahima Chowdhury, Taufiqur Rahman Bhuiyan, Afroza Akter, et al.
BMC Infectious Diseases|May 17, 2019
Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trialAshraful Islam Khan, Mohammad Ali, Julia Lynch, et al.
Pageof 8